ATC Abstracts

American Transplant Congress abstracts

2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions
View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm
NFκB Inhibitor Withaferin A Blocks IBMIR In Vitro: miRNA 375 Analysis.

M. Kanak,1 M. Takita,2 G. Yoshimatsu,2 M. Lawrence,2 M. Levy,1 B. Naziruddin.3

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
NKG2A-Expressing Natural Killer Cells Dominate the Response to Latent Epstein-Barr Virus Infection.

O. Hatton,1 D. Strauss-Albee,2 S. Krams,1 C. Blish,2 O. Martinez.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Nontuberculous Mycobacterial Infection Among Allogeneic Hematopoietic Stem Cell Transplant Recipients: A 16-Year Cohort Study.

A. Alghamdi, J. Lipton, C. Rotstein, D. Kumar, A. Humar, T. Mazzulli, S. Husain.

Poster Session D: Fungi, PJP, Mycobacteria, Infection Risk Factors, Vaccination and Donor Derived Infections  •  Halls C&D
6:00pm-7:00pm
Novel Approaches to Medication Teaching in Solid Organ Transplantation.

D. Tsapepas, N. Jandovitz, S. Dulanya, D. Salerno, S. Hammad, P. Jordan.

Poster Session D: Organizational and Operational Aspects of Transplantation  •  Halls C&D
6:00pm-7:00pm
Novel Effect of miR-26a:Mdm2:p53 Pathway on Mouse Liver Regeneration.

J. Zhou, W. Ju, X. Yuan, X. Jiao, D. Wang, X. Zhu, X. He.

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Novel Nuclear Factor-κB Activation Inhibitor, Dehydroxymethylepoxyquinomicin, Prevents the Development of Chronic Cyclosporine Nephropathy in Rats.

S. Morita,1 K. Shinoda,1 S. Tamaki,1 H. Kono,2 Y. Kanno,3 K. Umezawa,4 K. Nakagawa,2 M. Oya.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Nuclear Factor of Activated T-Cells Post-Renal Transplant.

K. Tornatore,1,4 K. Attwood,2 O. McGuire,3 K. O'Loughlin,3 R. Venuto,4 H. Minderman.3

Poster Session D: Poster Session II: Kidney Complications-Other  •  Halls C&D
6:00pm-7:00pm
Optimal Integration of Kidney Exchange Programs with Antibody Reduction Therapy to Increase Successful Transplant in Difficult to Match Recipients.

K. Melancon,1 N. Koizumi,2 M. Gentili,3 C. Callender.4

Poster Session D: Organizational and Operational Aspects of Transplantation  •  Halls C&D
6:00pm-7:00pm
Optimizing the Immunogenicity and Immunomodulatory Properties of MSC for Cellular Therapy.

S. de Witte,1 M. Franquesa,1 T. Strini,1 S. Korevaar,1 F. Luk,1 S. Elliman,2 P. Newsome,3 M. Gargesha,4 D. Roy,4 A. Merino,1 C. Baan,1 M. Hoogduijn.1

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection  •  Halls C&D
6:00pm-7:00pm
Outcome of Partial Reconstruction of Multiple Hepatic Arteries in Pediatric Living Donor Liver Transplantation Using Left Lateral Section Grafts.

K. Lee, K. Kim, S. Kim, J. Lee, J. Lee, N. Lee, C. Cho, S. Lee, G. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.

Poster Session D: Pediatric Liver Transplantation  •  Halls C&D